Stay updated on SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial
Sign up to get notified when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.

Latest updates to the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no visible changes to content or functionality on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision history updated to add v3.4.1 and remove v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedUI updates introduce glossary show/hide controls and a page revision label (v3.4.0), replacing the previous version. Additionally, several results-status labels were added or removed.SummaryDifference0.3%

- Check60 days agoChange DetectedThe revision history shows a minor update: Revision v3.3.4 was added and v3.3.3 was removed, with no impact on study data or documents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check88 days agoChange DetectedResults posting date (Results First Posted 2025-12-12) and enrollment (185) were added, along with a list of participating locations. The page now includes detailed outcome measures and their timeframes (ORR, DOR, DCR, PFS, OS).SummaryDifference5%

Stay in the know with updates to SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.